TACTICAL THERAPEUTICS
Tactical Therapeutics is a clinical-stage company that develops therapeutics for cancer.
TACTICAL THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.tacticaltherapeutics.com
Status:
Active
Contact:
(212) 651-9653
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Microsoft Exchange Online Office 365 Mail Pound Sterling Japanese Yen OpenResty Network Solutions
Similar Organizations
Allgenesis Biotherapeutics
Allgenesis Biotherapeutics is a clinical-stage ophthalmology company that develops small molecules and biologics for ophthalmic diseases.
Alyzen Medical Physics
Alyzen Medical Physics is a clinic-based company dedicated to developing solutions to treat cancer.
ARTARA THERAPEUTICS
ARTARA THERAPEUTICS is a healthcare company that develops medicare solutions for diseases therapeutics.
Inspyr Therapeutics
Inspyr Therapeutics is a clinical stage company focused on novel targeted precision therapeutics for the treatment of cancer.
Orange Therapeutics
Orange Therapeutics is a digital platform that offers medical practitioner-prescribed real-time therapeutic support at any time.
VasGene Therapeutics
VasGene Therapeutics is a clinical-stage company that develops therapeutics based on the understanding of vascular biology.
ViCardia
ViCardia is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Official Site Inspections
http://www.tacticaltherapeutics.com Semrush global rank: 16.17 M Semrush visits lastest month: 1
- Host name: 209.17.116.160
- IP address: 209.17.116.160
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Tactical Therapeutics"
Tactical Therapeutics: Overcoming Resistance in โฆ
Glioblastoma (grade IV astrocytoma) is an aggressive primary brain tumor that is extremely difficult to treat. There is an unmet medical need for treatment as the current prognosis is only 8.7% of patients surviving two years.See details»
TACTICAL THERAPEUTICS,INC | LinkedIn
Tactical Therapeutics, Inc, a Delaware Corp formed in 2005, has developed a patented cancer therapeutic, Carboxyamidotriazole Orotate (CTO), as an Orphan drug to treat glioblastoma (GBM ...See details»
Tactical Therapeutics - Crunchbase Company Profile
Tactical Therapeutics is a clinical-stage company that develops therapeutics for cancer.See details»
Tactical Therapeutics - PitchBook
Www.tacticaltherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Angel-Backed. Corporate Office. 48 Wall Street; 12th Floor; New York, NY 10005; United States +1 (917) Primary Industry. Drug โฆSee details»
Tactical Therapeutics, Inc - BIO CEO & Investor Conference | BIO
Feb 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
Tactical Therapeutics - Craft
Tactical Therapeutics (TTI) is a clinical-stage company that develops Carboxyamidotriazole Orotate (CTO) (Pravitinib), a therapeutic for the orphan indication glioblastoma (GBM) and โฆSee details»
Tactical Therapeutics - Overview, News & Similar companies
Tactical Therapeutics contact info: Phone number: (212) 651-9653 Website: www.tacticaltherapeutics.com What does Tactical Therapeutics do? Tactical Therapeutics, โฆSee details»
Tactical Therapeutics - Products, Competitors, Financials, โฆ
Tacticaltherapeutics.com. Overview & Products; Founded Year 2005. Mosaic Score. The Mosaic Score is an algorithm that measures the overall financial health and market potential of private โฆSee details»
Tactical Therapeutics, Inc., Developer of CTO Treatments for ...
Dec 13, 2022 Tactical Therapeutics, Inc., is a privately funded company that has developed a patented lead therapeutic, CTO, for glioblastoma and other solid cancers.See details»
Tactical Therapeutics, Inc. (Tactical Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
The purpose of this study is to determine the safety, tolerability, and the maximum tolerated dose/recommended phase II dose of carboxyamidotriazole orotate (CTO) as a single agent in โฆSee details»
Tactical Therapeutics CEO and Key Executive Team | Craft.co
Source: tacticaltherapeutics.com. Report incorrect company information. Key Executive Tracking. Receive notifications of key executive changes. Get started. Executives of similar companies. โฆSee details»
TACTICALTHERAPEUTICS.CO
Clinical Results of CTO. Two recent phase I studies of CTO in a refractory patient populations demonstrated that: CTO is safe and tolerable and has yet to reach MTD at up to 555 โฆSee details»
Tactical Therapeutics: Overcoming Resistance in Malignant Brain โฆ
Overcoming Resistance with first-in-class inhibitor of calcium signaling in solid cancers and glioblastomaSee details»
Tactical Therapeutics, Inc., Developer of CTO Treatments for
Dec 13, 2022 Tactical Therapeutics, Inc., Developer of CTO Treatments for Glioblastoma, Selected to Present at MedInvest Oncology Investor Conference December 14-15 in New โฆSee details»
Tactical Therapeutics, Inc., a clinical-stage biopharma company
Dec 7, 2022 Glioblastoma (GBM) is a life-threading disease, striking all corners of society regardless of gender, age, background, or income level. While there have been improvements โฆSee details»
Tactical Therapeutics Presents Trial Results for Glioblastoma โฆ
Nov 6, 2016 To read more about Tactical Therapeutics, please visit www.tacticaltherapeutics.com. Categories: COMPANIES. Post navigation. Stephen Chang โ โฆSee details»
Tactical Therapeutics Announces Publication of Promising Results โฆ
Apr 24, 2018 Tactical Therapeutics, Inc., a clinical stage biopharma, announced publication of โMulticenter Phase IB Trial of Carboxyamidotriazole Orotate and TemoSee details»
Tactical Therapeutics Presents Trial Results for Glioblastoma โฆ
Nov 6, 2016 Tactical Therapeutics, Inc., an emerging growth oncology drug development company, presented results of two Phase IB trials of its lead drug Carboxyamidotriazole โฆSee details»
Tactical Therapeutics Announces Publication of Promising Results โฆ
Apr 24, 2018 Tactical Therapeutics, Inc. Rashida Karmali, 212-651-9653 917-763-7196 [email protected] www.tacticaltherapeutics.com. Contacts ...See details»
BioWorldโs PARTNER in FOCUS - Tactical Therapeutics
NEW AND IMpROVED CTO ShOWS pROMISE BREAkThROuGhS IN CANCER ThERApy: O ne thing is certain about cancer treatment: The active ingredient must achieve high concentrations inSee details»